Schizophrenia Home > Versacloz and Pregnancy
It is generally considered safe for women to use Versacloz (clozapine oral suspension) when pregnant. This pregnancy Category B medicine has not been shown to cause problems to a developing fetus in animal studies or in cases where pregnant women used the drug. However, it should only be prescribed if the benefits outweigh the risks.
Versacloz™ (clozapine oral suspension) is a prescription medication approved to treat certain people with schizophrenia. Based on animal studies, this medication is probably safe for use during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Versacloz is classified as a pregnancy Category B medicine.
Pregnancy Category B is given to medicines that have not been adequately studied in pregnant humans but do not appear to cause harm to the fetus in animal studies. Medications that have been shown to be safe for use in pregnancy in humans but have caused problems in laboratory animals are also given a Category B rating.
Versacloz has not been adequately studied in pregnant women. In animal studies, the drug did not cause birth defects or other problems when given to pregnant rats and rabbits. There have also been reports of women using the drug during pregnancy and delivering healthy babies without birth defects.
However, it is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if her healthcare provider believes that the benefits to the woman outweigh any possible risks to her unborn child.